Go to Page # Page of 33

Success in CNS Drug Development: Innovation in Rare Diseases

 Stefan Weber, Ravi Anand, Roberto Galli, Marco Caremi, Dennis Dionne, Stephen Graham
  24th-Jun-2017
Description: This document has been prepared by Newron Pharmaceuticals S.p.A. ("Newron") solely for your information. The information contained herein has not been independently verified. No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained herein. Newron does not undertake any obligation to up-date or revise any information contained in this presentation. None of Newron, its advisors or any of their respective representatives or affiliates shall have any liability whatsoever (in negligence or otherwise) for any loss howsoever arising from any use of this document or its contents or otherwise arising in connection with this document. This copy of the presentation is strictly confidential and personal to the recipient. It may not be (i) used for any purpose other than in connection with the purpose of this presentation, (ii) reproduced or published, (iii) circulated to any person other than to whom it has been provided at this presentation.
Views: 1289
Domain: Medical
Category: Biology
Contributing Organization: Newron Pharmaceuticals
 ‐ More of their Presentations
Semiconductor Analytics
Contents:
SUCCESS IN CNS DRUG DEVELOPMENT –
INNOVATION IN RARE DISEASES
Corporate presentation
May 2017

Disclaimer
RESTRICTED SCOPE; EXCLUSION OF LIABILITY; CONFIDENTIALITY
This document has been prepared by Newron Pharmaceuticals S.p.A. ("Newron") solely for your information. The information contained herein has not been independently verified. No representation or warranty, express or implied, is ... See more

Recent Presentations

Jeff Olsen MD
15 December, 2017
...
14 December, 2017
...
13 December, 2017